Founder and Observer
Michael Rosenblatt was recently EVP and CMO for Merck until his retirement in 2016. Prior to joining Merck in 2009, he was Dean of Tufts University School of Medicine. Before that, he was the George R. Minot Professor of Medicine at Harvard Medical School 1998-2003. Dr. Rosenblatt has also served as Chief of the Division of Bone and Mineral Metabolism Research at Beth Israel Deaconess Medical Center, Harvard faculty dean, senior vice president for Academic Programs at CareGroup and Beth Israel Deaconess Medical Center, and Director of the Harvard-MIT Division of Health Sciences and Technology. Previously, Dr. Rosenblatt was Senior Vice President of Research and Vice President of Biological Research for Merck.